Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Janoueix-Lerosey, Isabelle" or (type any "bookEditor journalEditor issueEditor" and edito...

Add to list
Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

Jingwei Chen, Christopher Nelson, Matthew Wong, Andrew E. Tee, Pei Y. Liu, Ting La, Jamie I. Fletcher, Alvin Kamili, Chelsea Mayoh, Christoph Bartenhagen, et al.

(2021) CLINICAL CANCER RESEARCH. 27(5). p.1438-1451
Add to list
- Conference Paper
- C3
Identification of non-invasive biomarkers for treatment response in neuroblastoma by circulating miRNA profiling

Alan Van Goethem (UGent) , Nurten Yigit (UGent) , Mythala Moreno-Smith, Celine Everaert (UGent) , Olivier Delattre, Pieter Mestdagh (UGent) , Saurabh Agarwal, Eveline Barbieri, Isabelle Janoueix-Lerosey, Jason Shohet, et al.

(2016) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Irina Lambertz (UGent) , Candy Kumps (UGent) , Shana Claeys (UGent) , Sven Lindner, Anneleen Beckers (UGent) , Els Janssens, Daniel R Carter, Alex Cazes, Belamy B Cheung, Marilena De Mariano, et al.

(2015) CLINICAL CANCER RESEARCH. 21(14). p.3327-3339
Add to list
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz, Rene Schmidt, Andreas Faldum, Yvonne Kahlert, Anne Engesser, Shahab Asgharzadeh, et al.

(2015) CLINICAL CANCER RESEARCH. 21(8). p.1904-1915
Add to list
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma

Alex Cazes, Lucille Lopez-Delisle, Konstantina Tsarovina, Cécile Pierre-Eugène, Katleen De Preter (UGent) , Michel Peuchmaur, André Nicolas, Claire Provost, Caroline Louis-Brennetot, Romain Daveau, et al.

(2014) ONCOTARGET. 5(9). p.2688-2702
Add to list
Emergence of new ALK mutations at relapse of neuroblastoma

Gudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, Quentin Leroy, Julie Cappo, Thomas Rio Frio, Gaëlle Pierron, Eve Lapouble, Valérie Combaret, Franki Speleman (UGent) , et al.

(2014) JOURNAL OF CLINICAL ONCOLOGY. 32(25). p.2727-2734
Add to list
- Conference Paper
- C3
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

Pieter Mestdagh (UGent) , Erik Fredlund, Filip Pattyn (UGent) , Ali Rihani (UGent) , Tom Van Maerken (UGent) , Joëlle Vermeulen (UGent) , Candy Kumps (UGent) , Björn Menten (UGent) , Katleen De Preter (UGent) , Alexander Schramm, et al.

(2010) Advances in Genomics symposium, Abstracts.
Add to list
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

Sara De Brouwer (UGent) , Katleen De Preter (UGent) , Candy Kumps (UGent) , Piotr Zabrocki, Michael Porcu, Ellen M Westerhout, Arjan Lakeman, Jo Vandesompele (UGent) , Jasmien Hoebeeck (UGent) , Tom Van Maerken (UGent) , et al.

(2010) CLINICAL CANCER RESEARCH. 16(17). p.4353-4362
Add to list
Prognostic impact of gene expression-based classification for neuroblastoma

Andre Oberthuer, Barbara Hero, Frank Berthold, Dilafruz Juraeva, Andreas Faldum, Yvonne Kahlert, Shahab Asgharzadeh, Robert Seeger, Paola Scaruffi, Gian Paolo Tonini, et al.

(2010) JOURNAL OF CLINICAL ONCOLOGY. 28(21). p.3506-3515
Add to list
- Conference Paper
- C3
Genomic classification according to numerical and segmental chromosome instabilities is of strong prognostic relevance in neuroblastoma

Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Evi Michels, Veronique Mosseri, Agnes Ribeiro, Delphine Lequin, Joëlle Vermeulen (UGent) , Jo Vandesompele (UGent) , Gaelle Pierron, Jerome Couturier, et al.

(2007) PEDIATRIC BLOOD & CANCER. 49(4). p.431-432

Academic Bibliography

Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy

Identification of non-invasive biomarkers for treatment response in neuroblastoma by circulating miRNA profiling

Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma

Emergence of new ALK mutations at relapse of neuroblastoma

An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

Prognostic impact of gene expression-based classification for neuroblastoma

Genomic classification according to numerical and segmental chromosome instabilities is of strong prognostic relevance in neuroblastoma

Contents

Support

Contact